Akums Drugs & Pharmaceuticals Ltd — Q4 FY26
Akums Drugs reported a strong Q4 FY26 with consolidated revenue of ₹1,158 crore (+9.7% YoY) and adjusted EBITDA of ₹152 crore (+61.6% YoY), driven by robust CDMO volume growth o...
✓ Verified against BSE filing
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
Which internal capabilities are least scalable for regulated market ramp-up?
Asked by Sil Kapoor, Antifragile Thinking
Management listed existing capabilities but did not identify which is least scalable.
Read the exchange
as your European and regulated market business ramps, which is specific internal capabilities currently least scalable? Is it regulatory filing throughput or quality systems or tech transfer?
we already serve large Indian customers and MNC's Indian markets who themselves have a strict K sheet... we received the first European GMP approval way back in 22... plan 3 also received an visa approval this year
What is net effect on gross margin from negative and positive loops?
Asked by Sil Kapoor, Antifragile Thinking
Management did not quantify net effect, only described pass-through and R&D investment.
Read the exchange
what will be the net effect of one negative loop which is a cyclical loop... and the other one is much more structural loop which is a positive loop... what is the net effect on the gross margin in a nutshell?
as a business model it's a pass through business model. So whatever is the cost of input material gets passed on as part of a CDMO contracts... we have been investing over 100 crores in our R&D... we can gradually move up our gross margins.
What drives volume variance >25% and will price variance reverse?
Asked by Adja Sher, Incred Asset Management
Management attributed growth to existing customers but did not explain why volume surged.
Read the exchange
last two quarters the volume variance has been north of 25%. What is driving this and what is your outlook... price variance has been negative 3.5%... will this reverse going forward?
this is primarily led from existing customers only... increased demand for existing brands... similar double digit growth is also visible as we sit in May for the Q1... API prices have slightly gone up single high digits
Outlook for trade generics and API business, and tax rate for FY27?
Asked by Adja Sher, Incred Asset Management
Management gave qualitative outlook but no specific revenue or profit targets.
Read the exchange
how do you see the trade generate in API business for FI27 and beyond and a question on the tax rate accepted for FI27.
trade genic... is expected to remain at similar levels of revenue with similar levels of aida... API... we are hopeful we should do much better... tax rate... 29 on phone and overall is something we can build into our business models
Why did CDMO margins expand to 14.4% despite adverse product mix?
Asked by Pravin Jaman, Aventus Park
Management explained that prior year Q4 had low margins due to provisions and mix, so current Q4 is normal.
Read the exchange
in CDMO for Q4 SI26, our margins have expanded to 14.4%. Even though we had a product mix base which was diverse... how could this adverse mix improve our margins this quarter?
Q4 of 25 was an year where we had significant dip in aa driven again by the product portfolio and some year end provisions... in Q4 we had less of those low margin product and hence this looks to be an regular quarter.
Has Schedule M implementation improved visibility or customer inquiries?
Asked by Pravin Jaman, Aventus Park
Management explicitly declined to answer due to lack of visibility.
Read the exchange
the deadline has passed and inspections should have started... have we seen any visibility improvement... customers approaching us on this angle due to MSME's schedule M getting impact implemented?
I will like to skip this question because honestly we have no visibility on ground of how the government plans to roll this out.
What overall CDMO revenue growth and margins expected this year?
Asked by Ankurkumar, Alpha Capital
Management gave volume growth for H1 but no revenue or margin numbers.
Read the exchange
what kind of overall revenue growth are we expecting this year? ... overall what kind of revenue numbers and margins are we expecting?
we have visibility for 45 to 60 days of our revenue book... we expect a double digit volume growth right so while H2 still has to be seen... Similar margin profile what we currently have?
Purpose of land lease deed in Haridwar and expansion plans?
Asked by Rohit Banani, Vij Global
Management explained the land is for capacity expansion and utility support.
Read the exchange
execution of lease deed which we have done for land in Haiti. I wanted to know the purpose of you know this execution and expansion plans from this land in future.
this is simply one of those activities we will need for expansion of our capacities as well as building utility supports and so on.
Expected annual revenue from European contract of 200 million euros?
Asked by Rohit Banani, Vij Global
Management gave specific annual revenue of 35 million euros for the contract.
Read the exchange
European contract of 200 million euros. How much of this is expected from the first year? Will it be a 40 million euro commitment every year?
once we start we will have almost a 35 million euro on a matt basis... 35 for the next 6 years till 2032.
Why did international branded business revenue decline but margins improve to 28%?
Asked by Achel Mahishwari, Razer Investments
Management explained margin improvement due to marketing focus and forex gains.
Read the exchange
international branded business side... revenues have seen a sharp decline but the margins have improved to 28%. Is there a reason for that?
we are focusing on marketing of brands rather than just pure B2B play... also we got some benefits of the US so since it's USD we got some benefits from the forex gain... gross margins to be up by over 3 and a half 4%.
What was capex for FY26 and target for this year?
Asked by Dia, Safar Capital
Management provided specific capex numbers for FY26 and target for FY27.
Read the exchange
What was the KX for FI26 and how much are we going to spend in this year?
FYI26 we did a capex of 222 crores and this year we are targeting to keep our capex to a 300 crores.
Will CDMO margins improve to 15-16% with new contracts?
Asked by Nitesh, Christ Capital
Management agreed margins would improve but did not quantify to 15-16%.
Read the exchange
these contracts will effectively have... better margin... do we see a CDMO margin which has been in the 13 to 14% level improve to a 15 16% level.
We can think through that the base margins for the business once both of these contracts are in full swing will improve.
| Claim | Management said | Filing | Verdict |
|---|---|---|---|
| CDMO margin in Q4 FY26 was 14.4% | 14.4% | 13.1% | Overstated vs filing |
Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.